Rask-Madsen C[au] - Search Results

Year	Number of Results
1993	1
1994	1
1997	1
2001	3
2002	2
2003	3
2004	2
2005	5
2006	5
2007	1
2008	5
2010	5
2011	5
2012	6
2013	3
2016	4
2017	6
2018	2
2019	1
2021	1
2022	1

1

Letter by Rask-Madsen et al Regarding Article, "Selective Enhancement of Insulin Sensitivity in the Endothelium In Vivo Reveals a Novel Proatherosclerotic Signaling Loop".

Rask-Madsen C, Park K, Li Q, King GL. Rask-Madsen C, et al. Circ Res. 2017 Feb 17;120(4):e2-e3. doi: 10.1161/CIRCRESAHA.116.310491. Circ Res. 2017. PMID: 28209799 Free PMC article. No abstract available.

2

Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease.

Rask-Madsen C, Kahn CR. Rask-Madsen C, et al. Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2052-9. doi: 10.1161/ATVBAHA.111.241919. Arterioscler Thromb Vasc Biol. 2012. PMID: 22895666 Free PMC article. Review.

3

Vascular complications of diabetes: mechanisms of injury and protective factors.

Rask-Madsen C, King GL. Rask-Madsen C, et al. Cell Metab. 2013 Jan 8;17(1):20-33. doi: 10.1016/j.cmet.2012.11.012. Cell Metab. 2013. PMID: 23312281 Free PMC article. Review.

4

Kidney complications: factors that protect the diabetic vasculature.

Rask-Madsen C, King GL. Rask-Madsen C, et al. Nat Med. 2010 Jan;16(1):40-1. doi: 10.1038/nm0110-40. Nat Med. 2010. PMID: 20057426 Review. No abstract available.

5

The transcriptional coregulator CITED2 suppresses expression of IRS-2 and impairs insulin signaling in endothelial cells.

Kunkemoeller B, Chen K, Lockhart SM, Wang X, Rask-Madsen C. Kunkemoeller B, et al. Among authors: rask madsen c. Am J Physiol Endocrinol Metab. 2021 Aug 1;321(2):E252-E259. doi: 10.1152/ajpendo.00435.2020. Epub 2021 Jun 21. Am J Physiol Endocrinol Metab. 2021. PMID: 34151583 Free PMC article.

6

Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance.

Rask-Madsen C, King GL. Rask-Madsen C, et al. Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):487-96. doi: 10.1161/01.ATV.0000155325.41507.e0. Epub 2005 Jan 6. Arterioscler Thromb Vasc Biol. 2005. PMID: 15637306 Review.

7

Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.

Rask-Madsen C, King GL. Rask-Madsen C, et al. Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):46-56. doi: 10.1038/ncpendmet0366. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17179929 Review.

8

Insulin resistance in vascular endothelial cells promotes intestinal tumour formation.

Wang X, Häring MF, Rathjen T, Lockhart SM, Sørensen D, Ussar S, Rasmussen LM, Bertagnolli MM, Kahn CR, Rask-Madsen C. Wang X, et al. Among authors: rask madsen c. Oncogene. 2017 Aug 31;36(35):4987-4996. doi: 10.1038/onc.2017.107. Epub 2017 May 1. Oncogene. 2017. PMID: 28459466 Free PMC article.

9

Insulin decreases atherosclerosis by inducing endothelin receptor B expression.

Park K, Mima A, Li Q, Rask-Madsen C, He P, Mizutani K, Katagiri S, Maeda Y, Wu IH, Khamaisi M, Preil SR, Maddaloni E, Sørensen D, Rasmussen LM, Huang PL, King GL. Park K, et al. Among authors: rask madsen c. JCI Insight. 2016 May 5;1(6):e86574. doi: 10.1172/jci.insight.86574. JCI Insight. 2016. PMID: 27200419 Free PMC article.

10

Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes.

Li Q, Fu J, Xia Y, Qi W, Ishikado A, Park K, Yokomizo H, Huang Q, Cai W, Rask-Madsen C, Kahn CR, King GL. Li Q, et al. Among authors: rask madsen c. Nat Commun. 2019 Sep 27;10(1):4427. doi: 10.1038/s41467-019-12368-2. Nat Commun. 2019. PMID: 31562314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results